The present technology relates to implantable therapeutic devices and methods for endovascular placement of devices at a target site, such as an opening at a neck of an aneurysm. For example, selected embodiments of the present technology comprise shock absorbing structures that can inhibit dislodgement of the device relative to the aneurysm.
Many of the currently available surgical approaches for closing openings and repairing defects in anatomical lumens and tissues (e.g., blood vessels), septal defects, and other types of anatomical irregularities and defects are highly invasive. Surgical methods for clipping brain aneurysms, for example, require opening the skull, cutting or removing overlying brain tissue, clipping and repairing the aneurysm from outside the blood vessel, and then reassembling tissue and closing the skull. The risks related to anesthesia, bleeding, and infection associated with these types of procedures are high, and tissue that is affected during the procedure may or may not survive and continue functioning.
Minimally invasive techniques for treating aneurysms are accordingly highly desirable. In general, such minimally invasive therapeutic techniques help prevent material that collects or forms in the aneurysm cavity from entering the bloodstream and help prevent blood from entering and collecting in the aneurysm. This is often accomplished by introducing various materials and devices into the aneurysm. For example, implantable vaso-occlusive metallic structures are well known and commonly used. Many conventional vaso-occlusive devices have helical coils constructed from a shape memory material or noble metal that forms a desired coil configuration upon exiting the distal end of a delivery catheter. The function of the coil is to fill the space formed by an anatomical defect and to facilitate the formation of an embolus with the associated allied tissue. Multiple coils of the same or different structures may be implanted serially in a single aneurysm or other vessel defect during a procedure. Implantable framework structures are also used in an attempt to stabilize the wall of the aneurysm or defect prior to insertion of filling material such as coils. It is important to accurately implant vaso-occlusive devices within the internal volume of a cavity and to maintain the devices within the internal volume of the aneurysm. Migration or projection of a vaso-occlusive device from the cavity may interfere with blood flow or nearby physiological structures and can pose a serious health risk.
In addition to the difficulties of delivering implantable occlusion devices, some types of aneurysms are challenging to treat because of the particularities of the treatment site and/or the structural features of the aneurysm itself. Wide-neck aneurysms, for example, are known to present particular difficulty in the placement and retention of vaso-occlusive coils. Aneurysms at sites of vascular bifurcation are another example where the anatomical structure poses challenges to methods and devices that are effective in treating the typical sidewall aneurysms. It is therefore challenging to position conventional implantable devices during deployment, prevent shifting or migration of such devices after deployment, and preserve blood flow in neighboring vessels following deployment.
The present disclosure describes implantable therapeutic devices and methods for endovascular placement of devices at a target site, such as an opening at a neck of an aneurysm. In particular, selected embodiments of the present technology comprise shock absorbing structures that can inhibit dislodgement of the device relative to the aneurysm. The following description provides many specific details for a thorough understanding of, and enabling description for, embodiments of the disclosure. Well-known structures, systems, and methods often associated with such systems have not been shown or described in detail to avoid unnecessarily obscuring the description of the various embodiments of the disclosure. In addition, those of ordinary skill in the relevant art will understand that additional embodiments may be practiced without several of the details described below.
The closure structure 152 can be a frame, scaffold, or other structure that at least partially occludes the neck N of the aneurysm A to prevent embolic coils (shown in
In multiple device embodiments, the aneurysm device 150 may be deployed such that it is anchored along a specific portion of the neck N of the aneurysm A. As shown in
A proximally-extending portion 232 of the closure structure 152 may be coupled to a distally-extending portion 222 of the shock absorbing structure 101 by an attachment feature 230. In some embodiments, the attachment feature 230 comprises a solder attachment. In further embodiments, however, other attachment mechanisms can be used. The flexibility provided by the shock-absorbing assembly 220 and the attachment feature 230 is expected to inhibit movement of the supplemental stabilizer 153 relative to a vessel wall and help prevent movement in the blood vessel from dislodging the aneurysm device 150 after deployment.
Referring now to
An aneurysm device endovascularly deliverable to a site proximate to an aneurysm near a parent artery with bifurcating downstream branches, the aneurysm device comprising:
a closure structure comprising a distal-facing aspect configured to at least partially occlude the aneurysm;
a supplemental stabilizer connected to the closure structure, the supplemental stabilizer configured to reside in the parent artery and press outward against a luminal wall thereof; and
a shock absorbing structure coupled to a proximal end portion of the closure structure and to a distal end portion of the supplemental stabilizer.
The aneurysm device of example 1 wherein the shock absorbing structure comprises a spring.
The aneurysm device of example 2 wherein the spring comprises a leaf spring having a first spring arm and a second spring arm, and wherein the first and second spring aims at least partially surround an aperture.
The aneurysm device of example 3 wherein the first spring arm and the second spring aim extend laterally from at least one of the closure structure or the supplemental stabilizer.
The aneurysm device of example 2 wherein the supplemental stabilizer is configured to move proximally, distally, and/or laterally relative to the closure structure as the shock absorbing assembly exhibits spring movement.
The aneurysm device of example 1, further comprising an attachment feature configured to couple the closure structure to the shock absorbing structure.
The aneurysm device of example 6 wherein the attachment feature comprises hardened solder.
The aneurysm device of example 1 wherein the shock absorbing structure comprises a moveable junction between the closure structure and the supplemental stabilizer.
A system for treating an aneurysm, the system comprising:
a distal framework portion comprising a distal-facing aspect configured to enclose the aneurysm;
a proximal support framework connected to the distal framework portion, the support framework configured to reside in a parent artery and biased to press outward against a luminal wall thereof; and
a spring coupled to the distal framework portion and proximally movable relative to the distal framework portion.
The system of example 9 wherein the spring comprises a junction connecting the distal framework portion and the proximal support framework.
The system of example 9 wherein the spring comprises a leaf spring.
The system of example 9 wherein the distal framework portion comprises a set of distal struts forming at least one quadrilateral form with first and second longitudinal junctions, and wherein the system further comprises a barrier covering at least a portion of the distal struts.
The system of example 9 wherein the barrier comprises a membrane configured to enhance a separation between a cavity of the aneurysm and the parent artery.
A method of treating an aneurysm located at a site within a blood vessel, the method comprising:
positioning a framework comprising a distal portion and a proximal portion at a site proximate to the aneurysm;
applying a force outward from the proximal portion of the framework against a luminal wall of the blood vessel, and
absorbing movement of the framework relative to the blood vessel with a shock absorbing structure operably coupled with the framework.
The method of example 14 wherein absorbing movement of the framework comprises dampening movement of the framework relative to a blood vessel wall with the shock-absorbing structure.
The method of example 14 wherein absorbing movement of the framework comprises absorbing movement with a spring connecting the distal portion and the proximal portion.
The method of example 14 wherein absorbing movement of the framework comprises inhibiting dislodgement of the framework relative to the aneurysm.
The method of example 14 wherein absorbing movement of the framework comprises absorbing movement with a leaf spring.
The method of example 14 wherein absorbing movement of the framework comprises absorbing movement of the distal portion relative to the proximal portion.
The method of example 14, further comprising at least partially occluding the aneurysm with a barrier membrane coupled to the distal portion.
The above detailed descriptions of embodiments of the technology are not intended to be exhaustive or to limit the technology to the precise form disclosed above. Although specific embodiments of, and examples for, the technology are described above for illustrative purposes, various equivalent modifications are possible within the scope of the technology, as those skilled in the relevant art will recognize. For example, while steps are presented in a given order, alternative embodiments may perform steps in a different order. The various embodiments described herein may also be combined to provide further embodiments. In particular, the clot removal devices described above with reference to particular embodiments can include one or more additional features or components, or one or more of the features described above can be omitted.
From the foregoing, it will be appreciated that specific embodiments of the technology have been described herein for purposes of illustration, but well-known structures and functions have not been shown or described in detail to avoid unnecessarily obscuring the description of the embodiments of the technology. Where the context permits, singular or plural terms may also include the plural or singular term, respectively.
Moreover, unless the word “or” is expressly limited to mean only a single item exclusive from the other items in reference to a list of two or more items, then the use of “or” in such a list is to be interpreted as including (a) any single item in the list, B all of the items in the list, or (c) any combination of the items in the list. Additionally, the term “comprising” is used throughout to mean including at least the recited feature(s) such that any greater number of the same feature and/or additional types of other features are not precluded. It will also be appreciated that specific embodiments have been described herein for purposes of illustration, but that various modifications may be made without deviating from the technology. Further, while advantages associated with certain embodiments of the technology have been described in the context of those embodiments, other embodiments may also exhibit such advantages, and not all embodiments need necessarily exhibit such advantages to fall within the scope of the technology. Accordingly, the disclosure and associated technology can encompass other embodiments not expressly shown or described herein.
The present application is a U.S. National Stage of International Application No. PCT/US2012/040552, filed Jun. 1, 2012, entitled “SYSTEMS AND METHODS FOR ENCLOSING AN ANATOMICAL OPENING, INCLUDING SHOCK ABSORBING ANEURYSM DEVICES,” and claims the benefit of U.S. Provisional Patent Application No. 61/493,348, filed Jun. 3, 2011, both of which are incorporated herein by reference in their entirety.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/US2012/040552 | 6/1/2012 | WO | 00 | 4/30/2014 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2012/167150 | 12/6/2012 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
3868956 | Alfidi et al. | Mar 1975 | A |
4164045 | Bokros et al. | Aug 1979 | A |
4248234 | Assenza et al. | Feb 1981 | A |
4645495 | Vaillancourt | Feb 1987 | A |
4651751 | Swendson et al. | Mar 1987 | A |
4665906 | Jervis | May 1987 | A |
4706671 | Weinrib | Nov 1987 | A |
4710192 | Liotta et al. | Dec 1987 | A |
4739768 | Engelson | Apr 1988 | A |
4820298 | Leveen et al. | Apr 1989 | A |
4873978 | Ginsburg | Oct 1989 | A |
4909787 | Danforth | Mar 1990 | A |
4994069 | Ritchart et al. | Feb 1991 | A |
5011488 | Ginsburg | Apr 1991 | A |
5074869 | Daicoff | Dec 1991 | A |
5122136 | Guglielmi et al. | Jun 1992 | A |
5226911 | Chee et al. | Jul 1993 | A |
5250071 | Palermo | Oct 1993 | A |
5261916 | Engelson | Nov 1993 | A |
5263964 | Purdy | Nov 1993 | A |
5263974 | Matsutani et al. | Nov 1993 | A |
5271414 | Partika et al. | Dec 1993 | A |
5304195 | Twyford, Jr. et al. | Apr 1994 | A |
5334168 | Hemmer | Aug 1994 | A |
5342386 | Trotta | Aug 1994 | A |
5350397 | Palermo et al. | Sep 1994 | A |
5354295 | Guglielmi et al. | Oct 1994 | A |
5527338 | Purdy | Jun 1996 | A |
5531685 | Hemmer et al. | Jul 1996 | A |
5578074 | Mirigian | Nov 1996 | A |
5624449 | Pham et al. | Apr 1997 | A |
5643254 | Scheldrup et al. | Jul 1997 | A |
5665106 | Hammerslag | Sep 1997 | A |
5669931 | Kupiecki et al. | Sep 1997 | A |
5693067 | Purdy | Dec 1997 | A |
5733294 | Forber et al. | Mar 1998 | A |
5733329 | Wallace et al. | Mar 1998 | A |
5749890 | Shaknovich | May 1998 | A |
5749894 | Engelson | May 1998 | A |
5759194 | Hammerslag | Jun 1998 | A |
5766192 | Zacca | Jun 1998 | A |
5769884 | Solovay | Jun 1998 | A |
5797953 | Tekulve | Aug 1998 | A |
5814062 | Sepetka et al. | Sep 1998 | A |
5843103 | Wulfman | Dec 1998 | A |
D407818 | Mariant et al. | Apr 1999 | S |
5895391 | Farnholtz | Apr 1999 | A |
5895410 | Forber et al. | Apr 1999 | A |
5910145 | Fischell et al. | Jun 1999 | A |
5911737 | Lee et al. | Jun 1999 | A |
5916235 | Guglielmi | Jun 1999 | A |
5925060 | Forber | Jul 1999 | A |
5925062 | Purdy | Jul 1999 | A |
5925683 | Park | Jul 1999 | A |
5928260 | Chin et al. | Jul 1999 | A |
5933329 | Tijanoc et al. | Aug 1999 | A |
5935114 | Jang et al. | Aug 1999 | A |
5935148 | Villar et al. | Aug 1999 | A |
5951599 | McCrory | Sep 1999 | A |
5968068 | Dehdashtian et al. | Oct 1999 | A |
5980514 | Kupiecki et al. | Nov 1999 | A |
5980554 | Lenker et al. | Nov 1999 | A |
5984944 | Forber | Nov 1999 | A |
6007544 | Kim | Dec 1999 | A |
6013055 | Bampos et al. | Jan 2000 | A |
6022341 | Lentz | Feb 2000 | A |
6036720 | Abrams et al. | Mar 2000 | A |
6063070 | Eder | May 2000 | A |
6063104 | Villar et al. | May 2000 | A |
6071263 | Kirkman | Jun 2000 | A |
6077291 | Das | Jun 2000 | A |
6081263 | LeGall et al. | Jun 2000 | A |
6090125 | Horton | Jul 2000 | A |
6093199 | Brown et al. | Jul 2000 | A |
6096021 | Helm et al. | Aug 2000 | A |
6096034 | Kupiecki et al. | Aug 2000 | A |
6102917 | Maitland et al. | Aug 2000 | A |
6110191 | Dehdashtian et al. | Aug 2000 | A |
6117157 | Tekulve | Sep 2000 | A |
6139564 | Teoh | Oct 2000 | A |
6146339 | Biagtan et al. | Nov 2000 | A |
6152944 | Holman et al. | Nov 2000 | A |
6168615 | Ken et al. | Jan 2001 | B1 |
6168622 | Mazzocchi | Jan 2001 | B1 |
6174322 | Schneidt | Jan 2001 | B1 |
6183495 | Lenker et al. | Feb 2001 | B1 |
6193708 | Ken et al. | Feb 2001 | B1 |
RE37117 | Palermo | Mar 2001 | E |
6221066 | Ferrera et al. | Apr 2001 | B1 |
6221086 | Forber | Apr 2001 | B1 |
6224610 | Ferrera | May 2001 | B1 |
6228052 | Pohndorf | May 2001 | B1 |
6261305 | Marotta et al. | Jul 2001 | B1 |
6293960 | Ken | Sep 2001 | B1 |
6296622 | Kurz et al. | Oct 2001 | B1 |
6309367 | Boock | Oct 2001 | B1 |
6325807 | Que | Dec 2001 | B1 |
6344041 | Kupiecki et al. | Feb 2002 | B1 |
6344048 | Chin et al. | Feb 2002 | B1 |
6361558 | Hieshima et al. | Mar 2002 | B1 |
6375668 | Gifford et al. | Apr 2002 | B1 |
6383174 | Eder | May 2002 | B1 |
6398791 | Que et al. | Jun 2002 | B1 |
6478773 | Gandhi et al. | Nov 2002 | B1 |
6491711 | Durcan | Dec 2002 | B1 |
6517515 | Eidenschink | Feb 2003 | B1 |
6530935 | Wensel et al. | Mar 2003 | B2 |
6533905 | Johnson et al. | Mar 2003 | B2 |
6554794 | Mueller et al. | Apr 2003 | B1 |
6589256 | Forber | Jul 2003 | B2 |
6592605 | Lenker et al. | Jul 2003 | B2 |
6613074 | Mitelberg | Sep 2003 | B1 |
6616681 | Hanson et al. | Sep 2003 | B2 |
6626889 | Simpson et al. | Sep 2003 | B1 |
6626928 | Raymond et al. | Sep 2003 | B1 |
6638268 | Niazi | Oct 2003 | B2 |
6652556 | VanTassel et al. | Nov 2003 | B1 |
6663607 | Slaikeu et al. | Dec 2003 | B2 |
6663648 | Trotta | Dec 2003 | B1 |
6669795 | Johnson et al. | Dec 2003 | B2 |
6672338 | Esashi et al. | Jan 2004 | B1 |
6679836 | Couvillon, Jr. | Jan 2004 | B2 |
6679903 | Kurz | Jan 2004 | B2 |
6689141 | Ferrera et al. | Feb 2004 | B2 |
6694979 | Deem et al. | Feb 2004 | B2 |
6723112 | Ho et al. | Apr 2004 | B2 |
6740073 | Saville | May 2004 | B1 |
6740277 | Howell et al. | May 2004 | B2 |
6746468 | Sepetka et al. | Jun 2004 | B1 |
6780196 | Chin et al. | Aug 2004 | B2 |
6790218 | Jayaraman | Sep 2004 | B2 |
6802851 | Jones et al. | Oct 2004 | B2 |
6811560 | Jones et al. | Nov 2004 | B2 |
6824553 | Samson et al. | Nov 2004 | B1 |
6835185 | Ramzipoor et al. | Dec 2004 | B2 |
6837870 | Duchamp | Jan 2005 | B2 |
6843802 | Villalobos et al. | Jan 2005 | B1 |
6855153 | Saadat | Feb 2005 | B2 |
6863678 | Lee et al. | Mar 2005 | B2 |
6890218 | Patwardhan et al. | May 2005 | B2 |
6911037 | Gainor et al. | Jun 2005 | B2 |
6936055 | Ken et al. | Aug 2005 | B1 |
6939055 | Durrant et al. | Sep 2005 | B2 |
6986774 | Middleman et al. | Jan 2006 | B2 |
6994092 | van der Burg et al. | Feb 2006 | B2 |
7011094 | Rapacki et al. | Mar 2006 | B2 |
7033374 | Schaefer et al. | Apr 2006 | B2 |
7033387 | Zadno-Azizi et al. | Apr 2006 | B2 |
7122043 | Greenhalgh et al. | Oct 2006 | B2 |
7147659 | Jones | Dec 2006 | B2 |
7156871 | Jones et al. | Jan 2007 | B2 |
7169177 | Obara | Jan 2007 | B2 |
7229461 | Chin et al. | Jun 2007 | B2 |
7232461 | Ramer | Jun 2007 | B2 |
7267679 | McGuckin, Jr. et al. | Sep 2007 | B2 |
7306622 | Jones et al. | Dec 2007 | B2 |
7322960 | Yamamoto et al. | Jan 2008 | B2 |
7343856 | Blohdorn | Mar 2008 | B2 |
7387629 | Vanney et al. | Jun 2008 | B2 |
7410482 | Murphy et al. | Aug 2008 | B2 |
7569066 | Gerberding et al. | Aug 2009 | B2 |
7608088 | Jones et al. | Oct 2009 | B2 |
7662168 | McGuckin, Jr. et al. | Feb 2010 | B2 |
7857825 | Moran et al. | Dec 2010 | B2 |
7892254 | Klint et al. | Feb 2011 | B2 |
8016853 | Griffen et al. | Sep 2011 | B2 |
8075585 | Lee et al. | Dec 2011 | B2 |
8187315 | Clauson et al. | May 2012 | B1 |
8262692 | Rudakov | Sep 2012 | B2 |
8388650 | Gerberding et al. | Mar 2013 | B2 |
8444667 | Porter | May 2013 | B2 |
8470013 | Duggal et al. | Jun 2013 | B2 |
8540763 | Jones et al. | Sep 2013 | B2 |
8545530 | Eskridge et al. | Oct 2013 | B2 |
8551132 | Eskridge et al. | Oct 2013 | B2 |
8556953 | Berez et al. | Oct 2013 | B2 |
8715312 | Burke et al. | May 2014 | B2 |
8715338 | Frid | May 2014 | B2 |
8728141 | Riina et al. | May 2014 | B2 |
8747430 | Porter | Jun 2014 | B2 |
8771341 | Strauss et al. | Jul 2014 | B2 |
8915950 | Cam et al. | Dec 2014 | B2 |
8926680 | Ferrera et al. | Jan 2015 | B2 |
8956399 | Cam et al. | Feb 2015 | B2 |
8979893 | Gerberding et al. | Mar 2015 | B2 |
9060886 | Molaei et al. | Jun 2015 | B2 |
9107670 | Hannes et al. | Aug 2015 | B2 |
9119625 | Bachman et al. | Sep 2015 | B2 |
9179918 | Levy et al. | Nov 2015 | B2 |
9186267 | Losordo et al. | Nov 2015 | B2 |
9192388 | Cam et al. | Nov 2015 | B2 |
9211124 | Campbell et al. | Dec 2015 | B2 |
9259229 | Abrams et al. | Feb 2016 | B2 |
9277924 | Clarke et al. | Mar 2016 | B2 |
20020026232 | Marotta et al. | Feb 2002 | A1 |
20030033003 | Harrison | Feb 2003 | A1 |
20030057156 | Peterson et al. | Mar 2003 | A1 |
20030139802 | Wulfman et al. | Jul 2003 | A1 |
20030181922 | Alferness | Sep 2003 | A1 |
20030181942 | Sutton et al. | Sep 2003 | A1 |
20030195385 | DeVore | Oct 2003 | A1 |
20030195553 | Wallace et al. | Oct 2003 | A1 |
20030212412 | Dillard et al. | Nov 2003 | A1 |
20040044391 | Porter | Mar 2004 | A1 |
20040068314 | Jones et al. | Apr 2004 | A1 |
20040087998 | Lee et al. | May 2004 | A1 |
20040111112 | Hoffmann | Jun 2004 | A1 |
20040158311 | Berhow et al. | Aug 2004 | A1 |
20040167597 | Constantino et al. | Aug 2004 | A1 |
20040167602 | Fischell et al. | Aug 2004 | A1 |
20040172056 | Guterman et al. | Sep 2004 | A1 |
20040193246 | Ferrera | Sep 2004 | A1 |
20040210248 | Gordon et al. | Oct 2004 | A1 |
20040210298 | Rabkin et al. | Oct 2004 | A1 |
20050021023 | Guglielmi et al. | Jan 2005 | A1 |
20050025797 | Wang et al. | Feb 2005 | A1 |
20050033349 | Jones | Feb 2005 | A1 |
20050033409 | Burke | Feb 2005 | A1 |
20050096728 | Ramer | May 2005 | A1 |
20050177224 | Fogarty et al. | Aug 2005 | A1 |
20060004436 | Amarant et al. | Jan 2006 | A1 |
20060030929 | Musbach | Feb 2006 | A1 |
20060052862 | Kanamaru et al. | Mar 2006 | A1 |
20060058837 | Bose et al. | Mar 2006 | A1 |
20060064151 | Guterman et al. | Mar 2006 | A1 |
20060106418 | Seibold et al. | May 2006 | A1 |
20060200234 | Hines | Sep 2006 | A1 |
20060206199 | Churchwell et al. | Sep 2006 | A1 |
20060247680 | Amplatz et al. | Nov 2006 | A1 |
20060259131 | Molaei et al. | Nov 2006 | A1 |
20060264905 | Eskridge et al. | Nov 2006 | A1 |
20060264907 | Eskridge et al. | Nov 2006 | A1 |
20070067015 | Jones et al. | Mar 2007 | A1 |
20070088387 | Eskridge et al. | Apr 2007 | A1 |
20070106311 | Wallace et al. | May 2007 | A1 |
20070191884 | Eskridge et al. | Aug 2007 | A1 |
20070198075 | Levy | Aug 2007 | A1 |
20070203567 | Levy | Aug 2007 | A1 |
20070270902 | Slazas et al. | Nov 2007 | A1 |
20080004653 | Sherman et al. | Jan 2008 | A1 |
20080004692 | Henson et al. | Jan 2008 | A1 |
20080039930 | Jones et al. | Feb 2008 | A1 |
20080147100 | Wallace | Jun 2008 | A1 |
20080183143 | Palisis et al. | Jul 2008 | A1 |
20080221600 | Dieck et al. | Sep 2008 | A1 |
20080269774 | Garcia et al. | Oct 2008 | A1 |
20080319533 | Lehe | Dec 2008 | A1 |
20090069880 | Vonderwalde et al. | Mar 2009 | A1 |
20090125053 | Ferrera et al. | May 2009 | A1 |
20090306678 | Hardert et al. | Dec 2009 | A1 |
20100023105 | Levy et al. | Jan 2010 | A1 |
20100063531 | Rudakov et al. | Mar 2010 | A1 |
20100094335 | Gerberding et al. | Apr 2010 | A1 |
20110022149 | Cox | Jan 2011 | A1 |
20110270373 | Sampognaro et al. | Nov 2011 | A1 |
20120143237 | Cam et al. | Jun 2012 | A1 |
20120143317 | Cam et al. | Jun 2012 | A1 |
20120245674 | Molaei et al. | Sep 2012 | A1 |
20120290067 | Cam et al. | Nov 2012 | A1 |
20120296361 | Cam et al. | Nov 2012 | A1 |
20130090682 | Bachman et al. | Apr 2013 | A1 |
20130204290 | Clarke et al. | Aug 2013 | A1 |
20130268046 | Gerberding et al. | Oct 2013 | A1 |
20130268053 | Molaei et al. | Oct 2013 | A1 |
20130274862 | Cox et al. | Oct 2013 | A1 |
20130274863 | Cox et al. | Oct 2013 | A1 |
20130274866 | Cox et al. | Oct 2013 | A1 |
20130274868 | Cox et al. | Oct 2013 | A1 |
20130304109 | Abrams et al. | Nov 2013 | A1 |
20140052233 | Cox et al. | Feb 2014 | A1 |
20140058420 | Hannes et al. | Feb 2014 | A1 |
20140121752 | Losordo et al. | May 2014 | A1 |
20140128901 | Kang et al. | May 2014 | A1 |
20140142608 | Eskridge et al. | May 2014 | A1 |
20140180377 | Bose et al. | Jun 2014 | A1 |
20150039015 | Gerberding | Feb 2015 | A1 |
20150142025 | Brandeis | May 2015 | A1 |
20150142042 | Cox | May 2015 | A1 |
20150142043 | Furey | May 2015 | A1 |
20150157329 | Rudakov et al. | Jun 2015 | A1 |
20150157331 | Levy et al. | Jun 2015 | A1 |
20150164512 | Chin et al. | Jun 2015 | A1 |
20150164665 | Cam et al. | Jun 2015 | A1 |
20150182361 | Ferrera et al. | Jul 2015 | A1 |
20150196305 | Meyer et al. | Jul 2015 | A1 |
20150216534 | Riina et al. | Aug 2015 | A1 |
20150216687 | Gerberding et al. | Aug 2015 | A1 |
20150245932 | Molaei et al. | Sep 2015 | A1 |
20150250628 | Monstadt et al. | Sep 2015 | A1 |
20150282962 | Strauss et al. | Oct 2015 | A1 |
20150327867 | Bachman et al. | Nov 2015 | A1 |
20150342612 | Wu et al. | Dec 2015 | A1 |
20160015395 | Molaei et al. | Jan 2016 | A1 |
20160015396 | Cox et al. | Jan 2016 | A1 |
20160030050 | Franano et al. | Feb 2016 | A1 |
20160038153 | Losordo et al. | Feb 2016 | A1 |
20160249936 | Clarke et al. | Sep 2016 | A1 |
Number | Date | Country |
---|---|---|
2006304660 | Apr 2007 | AU |
1384726 | Dec 2002 | CN |
1399530 | Feb 2003 | CN |
1399531 | Feb 2003 | CN |
101489492 | Jul 2009 | CN |
102202585 | Sep 2011 | CN |
102762156 | Oct 2012 | CN |
103230290 | Aug 2013 | CN |
103381101 | Nov 2013 | CN |
103582460 | Feb 2014 | CN |
10200802830 | Apr 2009 | DE |
102008028308 | Apr 2009 | DE |
0820726 | Jan 1998 | EP |
1269935 | Jan 2003 | EP |
1527753 | May 2005 | EP |
2326259 | Jun 2011 | EP |
2451363 | May 2012 | EP |
2713904 | Apr 2014 | EP |
1134421 | Mar 2014 | HK |
2001286478 | Oct 2001 | JP |
2002516705 | Jun 2002 | JP |
2003512129 | Apr 2003 | JP |
2005522266 | Jul 2005 | JP |
2009512515 | Mar 2009 | JP |
2013226419 | Nov 2013 | JP |
20080081899 | Sep 2008 | KR |
WO-9724978 | Jul 1997 | WO |
WO-9726939 | Jul 1997 | WO |
WO-9731672 | Sep 1997 | WO |
WO-9823227 | Jun 1998 | WO |
WO-9850102 | Nov 1998 | WO |
WO-9905977 | Feb 1999 | WO |
WO-9907294 | Feb 1999 | WO |
WO-9915225 | Apr 1999 | WO |
WO-0013593 | Mar 2000 | WO |
WO-0130266 | May 2001 | WO |
WO-2001093782 | Dec 2001 | WO |
WO0200139 | Jan 2002 | WO |
WO-2002000139 | Jan 2002 | WO |
WO-0213899 | Feb 2002 | WO |
WO-02071977 | Sep 2002 | WO |
WO-02078777 | Oct 2002 | WO |
WO-02087690 | Nov 2002 | WO |
WO-03059176 | Jul 2003 | WO |
WO-03075793 | Sep 2003 | WO |
WO-04019790 | Mar 2004 | WO |
WO-04026149 | Apr 2004 | WO |
WO-04105599 | Dec 2004 | WO |
WO-05033409 | Apr 2005 | WO |
WO-05082279 | Sep 2005 | WO |
WO-2006119422 | Nov 2006 | WO |
WO-2007047851 | Apr 2007 | WO |
WO-2008151204 | Dec 2008 | WO |
WO-2010028314 | Mar 2010 | WO |
WO-2011029063 | Mar 2011 | WO |
WO-2012167137 | Dec 2012 | WO |
WO-2012167156 | Dec 2012 | WO |
WO-2013052920 | Apr 2013 | WO |
WO-2013169380 | Nov 2013 | WO |
WO-2014029835 | Feb 2014 | WO |
WO-2015179377 | Nov 2015 | WO |
Entry |
---|
Cordis NeuroVascular, Inc.; “Masstransit Microcatheter,” Product Prochure; No. 153-8383-3; Miami Lakes, FL, USA (2003). |
Cordis NeuroVascular, Inc.; “Prolwer Select Plus Microcatheter,” Product Brochure; No. 154-9877-1; Miami Lakes, FL, USA (2003). |
Cordis NeuroVascular, Inc.; “Prowler Select LP Microcatheter,” Product Brochure; No. 155-5585; Miami Lakes, FL, USA (2004). |
Cordis NeuroVascular, Inc.; “Rapid Transit Microcatheter,” Product Brochure; No. 152-7369-2; Miami Lakes, FL, USA (2003). |
Extended European Search Report, European Application No. 06826291.4, dated Nov. 19, 2009, 7 pages. |
Gupta et al. SMST-2003: Proc. Intl. Conf. Shape Memory Superelastic Technol.; Pacific Grove, CA; p. 639; 2003. |
International Search Report and Written Opinion for International Application PCT/US2013/031793, dated Jun. 26, 2013, 14 pages. |
International Search Report and Written Opinion for Application No. PCT/US2010/047908, dated May 25, 2011. |
International Search Report and Written Opinion for International Application No. PCT/US2009/056133, dated Oct. 26, 2009, 11 pages. |
International Search Report and Written Opinion for International Application No. PCT/US2010/047908, dated Mar. 15, 2012, 11 pages. |
International Search Report and Written Opinion for International Application No. PCT/US2012/040552, dated Aug. 28, 2012, 14 pages. |
International Search Report and Written Opinion for International Application PCT/US2012/040536, dated Oct. 15, 2012, 17 pages. |
International Search Report and Written Opinion for International Application PCT/US2012/040558, dated Oct. 8, 2012, 17 pages. |
International Search Report and Written Opinion for International Application PCT/US2012/059133, dated Mar. 11, 2013, 15 pages. |
International Search Report for International Application No. PCT/US06/40907, dated May 1, 2008, 2 pages. |
Micrus Copr.; “Concourse 14 Microcatheter” Product Brochure; Sunnyvale ,CA, USA. |
Polytetraflouroethylene Implants, DermNet NZ, Nov. 11, 2005, http://dermetnz.org/polytetrafluoroethylene.html. |
Singapore Examination Report for Singapore Application No. 200802811-0, dated Jul. 12, 2009, 7 pages. |
Number | Date | Country | |
---|---|---|---|
20140236216 A1 | Aug 2014 | US |
Number | Date | Country | |
---|---|---|---|
61493348 | Jun 2011 | US |